3 Ways to Incorporate Adaptive Trials into Your Oncology Drug Development Plans

Andrea Charles

The lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular tools in oncology research, helping to achieve validity, efficiency and speed in clinical development. In this interview Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc., join Andrea Charles from Pharma IQ to...
To continue reading this story get free access